Clinical Trials Sponsored by Cantex Healthcare Centers, LLC

Total 1232 results

Dr. Sidney J. Stohs
Telos Healthcare, LLC; Remarkable Healthcare; The Alden Network; Churchill Residential and other collaborators

Recruiting

Change in Antibody Levels Following SARS-CoV-2 (Covid-19) Vaccinations (Covid-19-Abs)

Covid-19 | Subjects Vaccinated Against Covid-19

United States
Synochi, LLC
LAC+USC Medical Center

Not yet recruiting

Prospective Placebo-controlled Study of Synochi Scar Spray

Burns Multiple
M.D. Anderson Cancer Center
GE Healthcare

Completed

Feasibility of Short Breast MRI (SBMRI) for Screening Patients at High Risk for Breast Cancer

Breast Cancer

United States
M.D. Anderson Cancer Center
GE Healthcare

Completed

Feasibility of Ultrasound Microbubble Contrast-Enhanced (CEUS) Sentinel Lymph Node Imaging With Guided Biopsy in Breast Cancer Patients

Breast Cancer

United States
M.D. Anderson Cancer Center
GE Healthcare

Withdrawn

A Pilot, Exploratory, Non-Randomized Study of PET/CT With the Investigational Agent [18F] Fluciclatide to Correlate With Response to Anti-Cancer Therapy

Advanced Cancers
M.D. Anderson Cancer Center
GE Healthcare

Active, not recruiting

Computed Tomography Urography (CTU) vs Intravenous Urography (IVU) on Patients at Risk of Urothelial Tumors

Bladder Cancer

United States
M.D. Anderson Cancer Center
GE Healthcare

Withdrawn

Fluoro-L-Thymidine Positron Emission Tomography (FLT PET) vs. Adv. Magnetic Resonance (MR) Techniques in Recurrent Glioma

Brain Tumor
M.D. Anderson Cancer Center
GE Healthcare

Completed

Motion Correction of Positron Emission Tomography (PET) Data Using Amplitude Gating

Lung Cancer

United States
Healthcare Center Murska Sobota

Completed

Screening for Hearth Rhythm Disorders

Cardiac Arrhythmia

Slovenia
Memorial Sloan Kettering Cancer Center
GE Healthcare

Completed

Digital Mammography for the Detection and Preoperative Staging of Breast Cancer

Breast Cancer

United States
Research Center, LLC

Completed

Clinical Evaluation of Effectiveness and Safety of Dietary Supplement Potensa in Men With Erectile Dysfunction

Erectile Dysfunction

Russian Federation
M.D. Anderson Cancer Center
Helsinn Healthcare SA

Withdrawn

Phase Ib Trial of Infigratinib In Combination With Atezolizumab And Bevacizumab for The Second-Line Treatment of Advanced Cholangiocarcinoma With FGFR2 Fusion/Amplification

Cholangiocarcinoma | Liver Cancer

United States
UNC Lineberger Comprehensive Cancer Center
GE Healthcare

Completed

Digital Breast Tomosynthesis Preference Study (NRR)

Breast Cancer

United States
M.D. Anderson Cancer Center
Helsinn Healthcare SA

Completed

Ruxolitinib and Pracinostat Combination Therapy for Patients With Myelofibrosis (MF)

Myeloproliferative Diseases

United States
Memorial Sloan Kettering Cancer Center
GE Healthcare

Completed

FACBC PET and PEM as a Staging Tool and Indicator of Therapeutic Response in Breast Cancer Patients

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center
GE Healthcare

Terminated

Breathing Synchronized PET/CT Scans for the Detection of Malignant Lung & Liver Lesions and Assessment of Tumor Glycolysis

Lung Cancer | Non-small Cell Lung Cancer

United States
M.D. Anderson Cancer Center
MedImmune LLC

Completed

Multi-Arm Study to Test the Efficacy of Immunotherapeutic Agents in Multiple Sarcoma Subtypes

Advanced and/or Metastatic Sarcoma

United States
M.D. Anderson Cancer Center
MedImmune LLC

Terminated

Study of Moxetumomab Pasudotox in Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia (ALL)

Leukemia

United States
M.D. Anderson Cancer Center
Pharmacyclics LLC.

Completed

Pilot Study to Determine Effects of the Btk Inhibitor PCI-32765 on Leukemia Cell Kinetics and Trafficking, Using Heavy Water Labeling in Subjects With CLL and SLL

Leukemia

United States
M.D. Anderson Cancer Center
Pharmacyclics LLC.

Completed

Phase 2 Study of the Combination of Bruton's Tyrosine Kinase Inhibitor PCI-32765 and Rituximab in High-Risk Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Patients

Leukemia

United States
M.D. Anderson Cancer Center
Pharmacyclics LLC.

Terminated

Ibrutinib Post Stem Cell Transplantation (SCT) in Double-Hit B-Cell Lymphoma

Lymphoma

United States
M.D. Anderson Cancer Center
Memgen, LLC

Withdrawn

Dose Escalation and Cohort Expansion of Safety and Tolerability Study of Intratumoral rAd.CD40L (ISF35) in Combination of Systemic Pembrolizumab in Patients With Refractory Metastatic Melanoma

Melanoma
Montefiore Medical Center
GE Healthcare

Recruiting

Virtual Colonoscopy Using Omnipaque as a Contrast Agent

Colorectal Cancer

United States
Boston Medical Center
ViiV Healthcare

Completed

Improving Treatment and Retention Adherence in Nontraditional Settings (I-TRAINS)

HIV Infections

United States
Tufts Medical Center
GE Healthcare

Completed

Influence of Beta Amyloid Imaging on Care of Patients Cognitive Complaints.

Mild Cognitive Impairment | Alzheimer's Disease

United States
Asan Medical Center
GE Healthcare

Completed

Oral Iohexol for Fecal/Fluid Tagging for CT Colonography: A Study to Improve Image Quality by Preventing Colonic Bubbles

Colorectal Neoplasms

Korea, Republic of
M.D. Anderson Cancer Center
Pharmacyclics LLC.

Active, not recruiting

Ibrutinib as Early Therapy in Chronic Lymphocytic Leukemia (CLL)

Chronic Lymphocytic Leukemia | Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic | Small Lymphocytic Leukemia

United States
Orlando Immunology Center
ViiV Healthcare

Recruiting

Changes in Immunologic Parameters Following the Addition of Fostemsavir in Virologically Suppressed Immunologic Non-responders Living With HIV-the RECOVER Study

HIV-1-infection

United States
Optimum Health, Natural Healthcare Center

Unknown

Chronic Lymphocytic Leukemia Responds to Dermal Chelation

Chronic Lymphocytic Leukemia
Asan Medical Center
GE Healthcare

Terminated

[18F]Fluciclatide PET Imaging of Pazopanib Response

Kidney Neoplasm

Korea, Republic of
M.D. Anderson Cancer Center
Gilero, LLC

Recruiting

Vapocoolant Analgesia for Breast Lymphoscintigraphy

Breast Cancer

United States
M.D. Anderson Cancer Center
MedImmune LLC

Terminated

Amifostine With IMRT for Submandibular and Sublingual Salivary Sparing During Head and Neck Cancer Treatment

Head and Neck Cancer

United States
Memorial Sloan Kettering Cancer Center
Fox Chase Cancer Center; Pharmacyclics LLC.

Terminated

Ibrutinib for Patients With Follicular Lymphoma Without Complete Response to Initial Chemoimmunotherapy

Follicular Lymphoma | Follicular Lymphoma, Grade 1 | Follicular Lymphoma, Grade 2 | Follicular Lymphoma Grade IIIa

United States
Palmetto Retina Center, LLC

Completed

A Safety and Efficacy Trial of a Treat and Extend Protocol Using Ranibizumab With and Without Laser Photocoagulation for Diabetic Macular Edema (TREX-DME)

Diabetic Macular Edema

United States
Palmetto Retina Center, LLC

Unknown

Treat and Extend Therapy Study Using Intravitreal Aflibercept for Patients Exited From Protocol VGFT-OD 0910 (RANGE)

Exudative Age-related Macular Degeneration

United States
Starx Research Center, LLC

Unknown

Ocular Allergy Treatment Practical Impact Trial ((OAT-PIT))

Allergic Conjunctivitis | Rhinoconjunctivitis

United States
Memorial Sloan Kettering Cancer Center
Pharmacyclics LLC.

Withdrawn

A Time-Limited Approach to Treatment With Ibrutinib for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | CLL | CLL/SLL | SLL

United States
Jonsson Comprehensive Cancer Center
Faxitron bioptics, LLC

Completed

SCOUT Reflector for Tagging Lymph Nodes for Targeted Removal in Patients With Breast Cancer

Stage I Breast Cancer AJCC v7 | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB... and other conditions

United States
Memorial Sloan Kettering Cancer Center
MedImmune LLC

Completed

Brain Irradiation and Tremelimumab in Metastatic Breast Cancer

Metastatic Breast Cancer

United States
King Hussein Cancer Center
Hikma Pharmaceuticals LLC

Completed

Use of Intravenous Ferric Carboxymaltose in Treatment of Anemia in Cancer Patients Undergoing Chemotherapy

Cancer | Anemia
M.D. Anderson Cancer Center
AstraZeneca; MedImmune LLC

Withdrawn

MEDI4736 With Selumetinib for KRAS Mutant Non-Small Cell Lung Cancer (NSCLC)

Malignant Neoplasm of Respiratory and Intrathoracic Organ Carcinoma | Advanced Lung Cancer | Recurrent Nonsmall Cell Lung Cancer
M.D. Anderson Cancer Center
Cubist Pharmaceuticals LLC

Completed

Daptomycin in the Treatment of Catheter-Related Staphylococcus Aureus

Staphylococcus Aureus

United States
M.D. Anderson Cancer Center
Janssen Services, LLC

Completed

Lenalidomide/Bortezomib/Dexamethasone & CNTO 328 in Transplant Eligible Newly Diagnosed Multiple Myeloma (MM)

Myeloma

United States
Midwest Bunion Center, LLC

Completed

Patient Reported Function Following Combined First MTP and First TMT Arthrodesis.

Hallux Valgus

United States
The Neuroscience Center, LLC

Completed

Neuromodulation to Facilitate the Effect of Ketamine (TMS/ketamine)

Depression | Chronic Pain | Substance Abuse

United States
Fred Hutchinson Cancer Center
Amazon.com Services LLC

Recruiting

Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma or Hormone Receptor Positive Her2 Negative Metastatic Refractory Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Cutaneous Melanoma | Unresectable Cutaneous Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Pathologic Stage IIID Cutaneous Melanoma AJCC... and other conditions

United States
M.D. Anderson Cancer Center
TerSera Therapeutics LLC

Recruiting

Telotristat Ethyl for the Treatment of Carcinoid Heart Disease in Patients With Metastatic Neuroendocrine Tumor

Locally Advanced Neuroendocrine Neoplasm | Metastatic Neuroendocrine Neoplasm

United States
Jonsson Comprehensive Cancer Center
POM Wonderful LLC

Completed

Pomegranate Juice in Treating Patients With Recurrent Prostate Cancer

Prostate Cancer

United States
M.D. Anderson Cancer Center
Cubist Pharmaceuticals LLC

Completed

Catheter Related - Gram Positive Bloodstream Infections

Bloodstream Infection

United States
M.D. Anderson Cancer Center
Amgen; Pharmacyclics LLC.

Terminated

Trial of PCI-32765 (BTK Inhibitor) in Combination With Carfilzomib in Relapse/Refractory Mantle Cell Lymphoma

Lymphoma

United States

Clinical Trials Sponsored by Cantex Healthcare Centers, LLC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Morocco

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations